Gideon Bollag
0000-0002-1824-6194
Plexxikon Inc
1 paper found
Refreshing results…
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD–mutant acute myeloid leukemia
Missing publications? Search for publications with a matching author name.